These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2720679)

  • 21. 3-(Tetraacetyl glucopyranos-2-yl)-1-(2-chloroethyl)-1-nitrosourea, an antitumor agent with modified bone marrow toxicity.
    Schein PS; McMenamin MG; Anderson T
    Cancer Res; 1973 Sep; 33(9):2005-9. PubMed ID: 4353476
    [No Abstract]   [Full Text] [Related]  

  • 22. Investigation of resistance to DNA cross-linking agents in 9L cell lines with different sensitivities to chloroethylnitrosoureas.
    Bodell WJ; Gerosa M; Aida T; Berger MS; Rosenblum ML
    Cancer Res; 1985 Aug; 45(8):3460-4. PubMed ID: 3860285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quinone-induced DNA damage and its relationship to antitumor activity in L5178Y lymphoblasts.
    Begleiter A; Blair GW
    Cancer Res; 1984 Jan; 44(1):78-82. PubMed ID: 6537800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo activity of 1-aryl-3-(2-chloroethyl) urea derivatives as new antineoplastic agents.
    Lacroix J; Gaudreault RC; Pagé M; Joly LP
    Anticancer Res; 1988; 8(4):595-8. PubMed ID: 3052247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo DNA cross-linking by cyclophosphamide: comparison of human chronic lymphatic leukemia cells with mouse L1210 leukemia and normal bone marrow cells.
    DeNeve W; Valeriote F; Edelstein M; Everett C; Bischoff M
    Cancer Res; 1989 Jul; 49(13):3452-6. PubMed ID: 2731167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antitumor effect of compounds synthesized in the Division of Synthetic Chemistry (V) (author's transl)].
    Miyahara M; Kamiya S; Nakadate M; Sueyoshi S; Tanno M; Miyahara M
    Eisei Shikenjo Hokoku; 1981; 99():111-3. PubMed ID: 7332796
    [No Abstract]   [Full Text] [Related]  

  • 27. Antitumor activity of the 3'-chloroethylnitrosourea analog of thymidine and the prevention by co-administered thymidine of lethality but not of anticancer activity.
    Lin TS; Fischer PH; Marsh JC; Prusoff WH
    Cancer Res; 1982 May; 42(5):1624-9. PubMed ID: 7066884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumor activity of novel ailanthone derivatives in vitro and in vivo.
    Kato T; Suzumura Y; Fukushima M; Honda T; Nakanishi T; Noguchi T
    Anticancer Res; 1988; 8(4):573-9. PubMed ID: 3178149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Disruption of DNA synthesis and structure of mouse L1210 leukemia cells, sensitive and resistant to 1-methyl-1 nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea in vivo].
    Kukushkina GV; Peretolchina NM; Minenkova EA; Verovskiĭ VN; Sof'ina ZP
    Biokhimiia; 1984 Jul; 49(7):1189-98. PubMed ID: 6477985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of nicotine with anticancer treatment.
    Berger MR; Zeller WJ
    Klin Wochenschr; 1988; 66 Suppl 11():127-33. PubMed ID: 3184771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug design: nitrosoureas.
    Eisenbrand G; Müller N; Schreiber J; Stahl W; Sterzel W; Berger MR; Zeller WJ; Fiebig H
    IARC Sci Publ; 1986; (78):281-94. PubMed ID: 3583393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of 1-(2-chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea on experimental tumors.
    Hisamatsu T; Uchida S
    Gan; 1977 Dec; 68(6):819-24. PubMed ID: 202535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride.
    Berners-Price SJ; Mirabelli CK; Johnson RK; Mattern MR; McCabe FL; Faucette LF; Sung CM; Mong SM; Sadler PJ; Crooke ST
    Cancer Res; 1986 Nov; 46(11):5486-93. PubMed ID: 3756897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in mice.
    Cantrell JE; Green D; Schein PS
    Cancer Res; 1986 May; 46(5):2340-3. PubMed ID: 2938728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chemotherapeutic characterization of new nitrosourea compounds].
    Zeller WJ; Berger MR; Eisenbrand G; Petru E
    Arch Geschwulstforsch; 1988; 58(3):137-49. PubMed ID: 3415433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of new nitrosoureas esters with modified steroidal nucleus for cytogenetic and antineoplastic activity.
    Hussein A; Mioglou-Kalouptsi E; Papageorgiou A; Karapidaki I; Iakovidou-Kritsi Z; Lialiaris T; Xrysogelou E; Camoutsis C; Mourelatos D
    In Vivo; 2007; 21(2):389-95. PubMed ID: 17436593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino)carbonylhydrazine (101M): a novel sulfonylhydrazine prodrug with broad-spectrum antineoplastic activity.
    Finch RA; Shyam K; Penketh PG; Sartorelli AC
    Cancer Res; 2001 Apr; 61(7):3033-8. PubMed ID: 11306484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological and biochemical properties of the 2-hydroxyl metabolites of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Heal JM; Fox PA; Doukas D; Schein PS
    Cancer Res; 1978 Apr; 38(4):1070-4. PubMed ID: 147730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The oncostatic and immunosuppressive action of new nitrosourea derivatives containing sugar radicals.
    Imbach JL; Montero JL; Moruzzi A; Serrou B; Chenu E; Hayat M; Mathe G
    Biomedicine; 1975 Dec; 23(10):410-3. PubMed ID: 1222217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological and preclinical toxicological studies of 1,2-diaminocyclohexane(isocitrato)platinum(II).
    Macquet JP; Cros S; Armand JP
    Cancer Res; 1984 Sep; 44(9):3736-43. PubMed ID: 6540142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.